Merck & Co., Inc.MRKNYSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.07% |
| Q3 2025 | 9.30% |
| Q2 2025 | 1.78% |
| Q1 2025 | -0.61% |
| Q4 2024 | -6.20% |
| Q3 2024 | 3.38% |
| Q2 2024 | 2.14% |
| Q1 2024 | 7.83% |
| Q4 2023 | -8.34% |
| Q3 2023 | 6.17% |
| Q2 2023 | 3.78% |
| Q1 2023 | 4.75% |
| Q4 2022 | -7.55% |
| Q3 2022 | 2.51% |
| Q2 2022 | -8.23% |
| Q1 2022 | 17.60% |
| Q4 2021 | 2.79% |
| Q3 2021 | 15.37% |
| Q2 2021 | 7.29% |
| Q1 2021 | -15.09% |
| Q4 2020 | 14.51% |
| Q3 2020 | 16.85% |
| Q2 2020 | -22.43% |
| Q1 2020 | 1.59% |
| Q4 2019 | -4.27% |
| Q3 2019 | 5.42% |
| Q2 2019 | 8.73% |
| Q1 2019 | -1.65% |
| Q4 2018 | 1.89% |
| Q3 2018 | 3.14% |
| Q2 2018 | 4.26% |
| Q1 2018 | -3.80% |
| Q4 2017 | 1.05% |
| Q3 2017 | 3.98% |
| Q2 2017 | 5.26% |
| Q1 2017 | -6.73% |
| Q4 2016 | -4.00% |
| Q3 2016 | 7.03% |
| Q2 2016 | 5.71% |
| Q1 2016 | -8.84% |